Other News To Note
Thursday, February 3, 2011
Metamark Genetics Inc., of Cambridge, Mass., reported that a prostate cancer study published in Nature described the identification of a key tumor suppressor of prostate cancer progression in mice and humans, and revealed four markers that are predictive of biochemical recurrence and lethal metastasis in human prostate cancer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.